- Home
- ANVS vs NAII Comparison
ANVS vs NAII Comparison
Compare ANVS & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- NAII
- Stock Information
- Founded
- ANVS 2008
- NAII 1980
- Country
- ANVS United States
- NAII United States
- Employees
- ANVS N/A
- NAII N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- NAII Medicinal Chemicals and Botanical Products
- Sector
- ANVS Health Care
- NAII Health Care
- Exchange
- ANVS Nasdaq
- NAII Nasdaq
- Market Cap
- ANVS 24.2M
- NAII 18.6M
- IPO Year
- ANVS 2020
- NAII 1987
- Fundamental
- Price
- ANVS $1.55
- NAII $3.24
- Analyst Decision
- ANVS Strong Buy
- NAII
- Analyst Count
- ANVS 4
- NAII 0
- Target Price
- ANVS $40.67
- NAII N/A
- AVG Volume (30 Days)
- ANVS 459.6K
- NAII 24.0K
- Earning Date
- ANVS 05-20-2025
- NAII 05-13-2025
- Dividend Yield
- ANVS N/A
- NAII N/A
- EPS Growth
- ANVS N/A
- NAII N/A
- EPS
- ANVS N/A
- NAII N/A
- Revenue
- ANVS N/A
- NAII $121,853,000.00
- Revenue This Year
- ANVS N/A
- NAII N/A
- Revenue Next Year
- ANVS N/A
- NAII N/A
- P/E Ratio
- ANVS N/A
- NAII N/A
- Revenue Growth
- ANVS N/A
- NAII N/A
- 52 Week Low
- ANVS $1.11
- NAII $2.57
- 52 Week High
- ANVS $17.88
- NAII $7.26
- Technical
- Relative Strength Index (RSI)
- ANVS 56.90
- NAII 55.09
- Support Level
- ANVS $1.42
- NAII $2.69
- Resistance Level
- ANVS $1.75
- NAII $3.37
- Average True Range (ATR)
- ANVS 0.15
- NAII 0.28
- MACD
- ANVS 0.04
- NAII 0.06
- Stochastic Oscillator
- ANVS 84.62
- NAII 70.24
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.